Pancreatic islet transplantation

PLoS Medicine

Volumn 1, Issue 3, 2004, Pages 198-201

  Naftanel, Mark A ^c   Harlan, David M ^a,b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; INSULIN; RAPAMYCIN; STEROID; TACROLIMUS; ANTIDIABETIC AGENT;

ANEMIA; ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIARRHEA; FATIGUE; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; HEALTH HAZARD; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY FAILURE; MEDICAL RESEARCH; MOUTH ULCER; NEPHROTOXICITY; NONHUMAN; PANCREAS INSUFFICIENCY; PANCREAS ISLET TRANSPLANTATION; PERIPHERAL EDEMA; PROGNOSIS; RISK ASSESSMENT; SAFETY; SIDE EFFECT; WEIGHT REDUCTION; HISTORY; METHODOLOGY; PATHOLOGY; REVIEW;

DIABETES MELLITUS, TYPE 1; HISTORY, 20TH CENTURY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION;

EID: 15744381397     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0010058     Document Type: Article

References (17)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053.
2. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J (1999) Worldwide increase in incidence of type I diabetes - The analysis of the data on published incidence trends. Diabetologia 42: 1395-1403.
3. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
4. [Anonymous] (1999) Epidemiology of Diabetes Interventions and Complications [EDIC]. Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22: 99-111.
5. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2003) Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290: 2159-2167.
6. Nishimura R, LaPorte RE, Dorman JS, Tajima N, Becker D, et al. (2001) Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965-1999. Diabetes Care 24: 823-827.
7. Harlan DM (2004) Gene-altered islets for transplant: Giant leap or small step? Endocrinology 145: 463-466.
8. Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, et al. (2003) Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 290: 2817-2823.
9. Lacy PE, Kostianovsky M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39.
10. Kemp CB, Knight MJ, Scharp DW, Lacy PE, Ballinger WF (1973) Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature 244: 447.
11. Scharp DW, Murphy JJ, Newton WT, Ballinger WF, Lacy PE (1975) Transplantation of islets of Langerhans in diabetic rhesus monkeys. Surgery 77: 100-105.
12. Lacy PE (1978) Workshop on Pancreatic Islet Cell Transplantation in Diabetes sponsored by the National Institute of Arthritis, Metabolism, and Digestive Diseases and held at the National Institutes of Health in Bethesda, Maryland, on November 29 and 30, 1977. Diabetes 27: 427-429.
13. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-238.
14. Robertson RP (2004) Islet transplantation as a treatment for diabetes - A work in progress. N Engl J Med 350: 694-705.
15. Hirshberg B, Rother KI, Digon BJ III, Lee J, Gaglia JL, et al. (2003) Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: The National Institutes of Health experience. Diabetes Care 26: 3288-3295.
16. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, et al. (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349: 931-940.
17. Stern Z, Levy R (1996) Analysis of direct cost of standard compared with intensive insulin treatment of insulin-dependent diabetes mellitus and cost of complications. Acta Diabetol 33: 48-52.